What is the global market size of Wearable Injectors Market?

Wearable Injectors Market size was valued at USD 6.66 billion in 2021 and is poised to grow from USD 7.65 billion in 2022 to USD 23.89 billion by 2030, growing at a CAGR of 15.29% in the forecast period (2023-2030).

Global Wearable Injectors Market Size, Share, Growth Analysis, By Type(On-Body, Off-Body), By Therapy(Diabetes, Cardiovascular disease) - Industry Forecast 2024-2031

Report ID: SQSG35B2020 | Region: Global | Published Date: February, 2024
Pages: 263 | Tables: 63 | Figures: 76

Global Wearable Injectors Market Insights

Wearable Injectors Market size was valued at USD 6.66 billion in 2019 and is poised to grow from USD 7.65 billion in 2023 to USD 23.89 billion by 2031, growing at a CAGR of 15.29% in the forecast period (2024-2031).

Wearable injectors are delivery methods that stick to the skin and allow for long-term subcutaneous drug administration. The equipment in wearable injectors gives more accurate dosing, along with other clinical advantages, and higher delivery precision. The components of any wearable injector are the same: a reservoir for medication, a cannula for tissue supply, an adhesion to secure the equipment to the skin's surface, and a driving mechanism to provide the right amount of medication.

Comparing wearable injectors to traditional injecting techniques, they are a more affordable form of administration. The market for wearable injectors is expected to develop as a result of the advantages these devices have over traditional injections, including better drug dose and time control, enhanced patient ease and satisfaction, and a decrease in methodological problems. But throughout the projected timeline, unfavorable reimbursement rules are expected to slow the rising demand for wearable injectors.

US Wearable Injectors Market is poised to grow at a sustainable CAGR for the next forecast year.

Global Wearable Injectors Market Report Snapshots

License Type Top market research company in USA

File Type

$5,300

BUY NOW GET FREE SAMPLE

Want to customize this report?

Our industry expert will work with you to provide you with customized data in a short amount of time.

REQUEST FREE CUSTOMIZATION

FAQs

Many businesses in the market for producing wearable injectors are now concentrating on expanding their production capacities through mergers and acquisitions. For the purpose of acquiring new features or gaining entry into new markets, large primary manufacturers are creating joint ventures or purchasing small or midsized businesses. Additionally, businesses are investing in the creation of enhanced products. They are also concentrating on keeping their prices competitive. For instance, in April 2021, the Medtronic Extended infusion set is the first and only infusion set that may be worn for up to 7 days, according to an announcement made by Medtronic plc. 'Ypsomed', 'Amgen', 'Subcuject (Denmark)', 'Becton, Dickinson and Company (BD)', 'Bespak Europe Ltd.', 'CeQur SA', 'Debiotech SA', 'Enable Injections', 'Insulet Corporation', 'Medtronic plc', 'Mylan N.V.', 'Nemera Development S.A.', 'Omron Corporation', 'Pfizer Inc.', 'Roche Holding AG', 'Sensile Medical AG', 'SteadyMed Therapeutics, Inc.', 'Tandem Diabetes Care, Inc.', 'United Therapeutics Corporation', 'West Pharmaceutical Services, Inc.', 'Zosano Pharma Corporation'

The choice of different medicines and wearable drug delivery systems has increased as a result of the uncertainty surrounding the COVID-19 pandemic. To stop the illness from spreading and protect high-risk individuals from illness, medical systems on the planet have taken action to delay the onset of cancer therapies. As the pandemic spread, the risks for those obtaining medical attention increased. The majority of patients are treated in hospitals, which increased their danger during the outbreak. A shift from hospital-based therapy to home-based care has taken place in order to solve these challenges and give adequate care to individuals suffering from various illnesses.

The rising popularity of at-home, self-administered injectors for treating illnesses with little chance of dosage error and needle stick injuries. Other growth-promoting aspects include a number of product developments, such as the incorporation of Bluetooth, wireless communication, and passive warning systems with injectors. These innovations allow for comfortable patient monitoring via a mobile application and offer prompt medication reminders.

In terms of revenue, North America held the largest wearable injector market globally in 2021, and it is expected that it will continue to do so during the projection timeframe. This is explained by the spike in the number of people with various medical conditions. Furthermore, the requirement for the wearable injector market is being fueled by the introduction of numerous novel medications that may successfully cure chronic diseases. Additionally, the growing acceptance of tailored pharmaceuticals may have a favorable effect on the market in the years to come.

Feedback From Our Clients

"We have purchased recently a report from SkyQuest Technology, and we are happy to inform you that this report was so useful and practical for our team. Skyquest Team was very active and our queries were followed up completely.It was amazing. "

- Mr. Ali Zali, Commercial Director, ICIIC Iran.

Global Wearable Injectors Market Size, Share, Growth Analysis, By Type(On-Body, Off-Body), By Therapy(Diabetes, Cardiovascular disease) - Industry Forecast 2024-2031

Global Wearable Injectors Market Insights

Global Wearable Injectors Market Report Snapshots

Want to customize this report?

FAQs

What is the global market size of Wearable Injectors Market?

Who are the key vendors in the Global Wearable Injectors Market?

What is the key driver of Global Wearable Injectors Market?

What is the key market trend for Global Wearable Injectors Market?

Which region accounted for the largest share in Global Wearable Injectors Market?

Request Free Customization

Related Reports

Feedback From Our Clients

$5,300